VALYSTR · Stock research
Listed on OTC Markets OTCID. What the market is pricing into Hypera S.A. (HYPMY) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Pharmaceuticals · market value about $2.7B · P/E 7.8 (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows